All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
TEVA total return snapshot: TEVA returned +105.09% over the past year and +31.69% YTD, with dividends reinvested. Since Feb. 16, 1982, TEVA is up +13,257.17% in nominal total return, or +11.59%/yr, and is currently −38.65% below its total-return high on Jul. 27, 2015.
Data ending Fri Oct. 9, 2026
| Tue 1982-02-16💬 to Fri 2026-10-09 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| TEVA × |
+13,257.17%
+11.59%/yr |
+14.16%/yr
R2=0.688 |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||
| Tue 1982-02-16💬 to Fri 2026-10-09 |
Start
Value |
End
Value |
|---|---|---|
| TEVA × |
$10,000.00
1982-02-16 |
$1,335,716.61
2026-10-09 |
| YTD | YoY | |
|---|---|---|
| TEVA × | +31.69% | +105.09% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| TEVA × |
−38.65%
on 2026-10-09 from 2015-07-27 peak |
−93.11%
on 1984-11-19 |
| Period ending Fri 2026-10-09 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| TEVA × | +105.09% |
+131.81% +52.25%/yr |
+365.99% +67.03%/yr |
+304.53% +32.25%/yr |
−4.84% −0.50%/yr |
| Year | TEVA |
|---|---|
| 2026 (YTD) | +31.69% |
| 2025 | +41.61% |
| 2024 | +111.11% |
| 2023 | +14.47% |
| 2022 | +13.86% |
| 2021 | −16.99% |
| 2020 | −1.53% |
| 2019 | −36.45% |
| 2018 | −18.63% |
| 2017 | −45.96% |
| 2016 | −43.20% |
| 2015 | +16.71% |
| 2014 | +47.36% |
| 2013 | +10.91% |
| 2012 | −5.10% |
| 2011 | −21.03% |
| 2010 | −5.89% |
| 2009 | +33.61% |
| 2008 | −7.39% |
| 2007 | +50.98% |
| 2006 | −24.27% |
| 2005 | +50.73% |
| 2004 | +10.96% |
| 2003 | +49.69% |
| 2002 | +27.40% |
| 2001 | −14.96% |
| 2000 | +106.82% |
| 1999 | +78.16% |
| 1998 | −12.04% |
| 1997 | −5.42% |
| 1996 | +9.47% |
| 1995 | +94.20% |
| 1994 | −18.61% |
| 1993 | +38.40% |
| 1992 | +133.92% |
| 1991 | +65.73% |
| 1990 | −0.83% |
| 1989 | +73.43% |
| 1988 | +10.69% |
| 1987 | +0.36% |
| 1986 | +132.21% |
| 1985 | +210.49% |
| 1984 | −32.37% |
| 1983 | −73.44% |
| 1982 | −44.82% |
